FILE:AET/AET-8K-20080806160205.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
Section 5  Corporate Governance and Management
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On August 4, 2008, Aetna Inc. (Aetna) announced that Rajan Parmeswar was appointed Vice President, Controller and Chief Accounting Officer of Aetna.  Mr. Parmeswar is expected to commence employment at Aetna on August 18, 2008.  Mr. Parmeswar succeeds Ronald M. Olejniczak who, as previously announced, retired from Aetna on July 31, 2008.
 
Mr. Parmeswar, age 46, is a certified public accountant and is currently an audit partner at Pricewaterhouse Coopers LLP, a position he has held since 1998.  Mr. Parmeswar joined Pricewaterhouse Coopers LLP in 1989.
 
The key terms of Mr. Parmeswars compensation arrangements are as follows:
* Reflects the theoretical grant date value of the SARs to be granted. The strike price and the number of SARs will be determined using Aetnas closing stock price on the grant date and a SAR valuation factor of 30% (i.e., the number of SARs granted will be equal to the dollar value of the theoretical grant date value divided by a factor determined by multiplying Aetnas closing stock price on the grant date by 30%).
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


